ArticlePharmaceutics2025

Matrix Approach Assessment of Cabotegravir Drug-Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling.

Helen Tracey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.